Dr. White on Ablative Radiotherapy for MBC

Partner | Cancer Centers | <b>The Ohio State University</b>

Julia White, MD, professor, director, Breast Radiation Oncology, vice chair, Clinical Research, The Ohio State University Comprehensive Cancer Center, discusses the use of ablative radiotherapy in patients with metastatic breast cancer.

Julia White, MD, professor, director, Breast Radiation Oncology, vice chair, Clinical Research, The Ohio State University Comprehensive Cancer Center, discusses the use of ablative radiotherapy in patients with metastatic breast cancer.

White says an ablative radiotherapy approach to metastatic regions allows a patient to not have to undergo a surgical procedure. Even though surgical procedures are typically well tolerated, there are inherent risks of both anesthesia and complications following surgery.

When metastatic breast cancer patients have to undergo surgery, they have to stop systemic therapy, White says, which interrupts the treatment process. With an ablative radiotherapy approach, there are no treatment interruptions.